1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 15 SEPTEMBER 2014

Key Pharma News 15 SEPTEMBER 2014

  • September 2014
  • -
  • Espicom Business Intelligence
  • -
  • 35 pages

Industry Trend Analysis - Merck Beats BMS To Market With Anti-PD-1 Therapy
Industry Trend Analysis - Calico Collaboration To Further Expand AbbVie's Portfolio
Industry Brief - Chugai Amends Business Arrangements With Roche
Industry Brief - AstraZeneca/Redx Enter Oncology Research Collaboration
Industry Trend Analysis - Infinity Soars As It Enters Duvelisib Agreements
Industry Brief - Pfizer/Astellas Terminate Co-Promotion/Distribution Agreement In Japan
Industry Trend Analysis - Boom In Antibody-Drug Conjugate Market On The Horizon
Industry Trend Analysis - Endo's Fling With Medical Devices Market Likely To End
Industry Brief - Merck Serono Breaks Ground For New Pharmaceutical Manufacturing Facility In China
Industry Trend Analysis - Apotex Loses NAFTA Claim Against US
Industry Brief - Novo Nordisk Acquires New Hampshire Facility From Olympus Biotech
Industry Trend Analysis - InterMune Acquisition Pits Roche Against BI In IPF Market
Industry Trend Analysis - Novo Nordisk Halts Inflammation Work
Industry Trend Analysis - Increasing Prevalence of MDR-TB To Aid Deltyba Sales
Industry Brief - FDA Approves Use Of Menactra Against Meningococcal Disease
Industry Brief - FDA Accepts Actavis' NDA Filing For Ceftazidime-Avibactam
Industry Trend Analysis - Sales Of UCB's Vimpat To Grow Further As FDA Approves MT Indication
Industry Brief - EC Approves Triumeq Single-Tablet Regimen For HIV
Industry Trend Analysis - Tesaro's Rolapitant On Course To Compete With Merck's Emend In 2015
Industry Brief - TWi Gains US Megestrol Approval
Industry Trend Analysis - MAA Moves Amgen Closer To Capitalising On Potential Of Oncolytic Immunotherapy
Industry Brief - GSK Receives FDA Approval Of Promacta In SAA Patients
Industry Brief - Vivus Acquires Topiramate-Related Patents From Janssen
Industry Trend Analysis - UK Drug Pricing Changes Put On Hold; Temporary CDF Initiative Continues
Industry Brief - Amgen Submits Evolocumab BLA To FDA
Industry Brief - FDA Approves Elelyso For Paediatric Type 1 Gaucher Disease Patients
Industry Brief - Northera Available In US For Symptomatic NOH
Industry Brief - NICE Recommends Biogen Idec's Tecfidera For RRMS
Industry Brief - Biogen Idec's Eloctate Secures Health Canada Approval
Industry Brief - Canaglu Launched In Japan For Type II Diabetes
Industry Brief - Amgen Submits Evolocumab MAA To EMA
Industry Brief - Takeda Submits Leuplin Six Month Depot NDA In Japan
Industry Brief - Filings Accepted For Somatuline In Treatment Of GEP-NETs
Industry Brief - FDA Accepts NDA Filing For Eluxadoline; Grants Priority Review
Industry Brief - Teva Receives US Entecavir Approval
Industry Brief - Eisai Sells US/Puerto Rican Zonegran Rights To Concordia
Industry Brief - Chugai Launches Alecensa In Japan
Industry Brief - FDA Approves Epaned For Treating HF/Asymptomatic Left Ventricular Dysfunction
Industry Brief - FDA Accepts Astellas' Isavuconazole NDA For Invasive Aspergillosis/Mucormycosis
Industry Trend Analysis - Spiriva Respimat Inhaler Indications Expand With Untapped Asthma Market Potential
Industry Trend Analysis - Positive Phase III Results Take Sanofi A Step Closer To Dominating Dengue Market
Industry Trend Analysis - Ebola Outbreak Causes Surge In Previously Non-Existent Market
Industry Trend Analysis - Exelixis Cuts Jobs As Lead Compound Fails Phase III Trials
Industry Brief - Reslizumab Phase III Studies Meet Primary Endpoint
Industry Brief - J&J Accelerates Ebola Vaccine Programme
Industry Trend Analysis - Nuplazid's FDA Breakthrough Therapy Designation Boosts ACADIA
Industry Brief - Positive Results For Tetraphase's Eravacycline In Phase III cUTIs Trial
Industry Trend Analysis - Incentive Schemes Increasing Anti-Infectives R&D
Industry Brief - First Patient Enrolled in ThermoDox Phase III HCC Study
Industry Trend Analysis - Xilonix Study Records Positive Interim Results As Protocol Amended
Industry Trend Analysis - Positive Basal Insulin Peglispro Results Reveal New Threat To Lantus
Industry Trend Analysis - Hyperion's Pipeline Depleted As Trial Misconduct Terminates DiaPep277 Development

Table Of Contents

Key Pharma News 15 SEPTEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.